首页> 中国专利> 生脉饮在预防、治疗雾霾促发心肌缺血性疾病中的作用

生脉饮在预防、治疗雾霾促发心肌缺血性疾病中的作用

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明属于医药技术领域，涉及一种药物组合物的新用途，特别涉及生脉饮在预防、治疗雾霾促发心肌缺血性疾病中的应用。

著录项

公开/公告号CN104940595A

专利类型发明专利
公开/公告日2015-09-30

原文格式PDF
申请/专利权人中国中医科学院中药研究所;
展开▼

申请/专利号CN201510422625.1
发明设计人朱晓新;李玉洁;陈颖;杨庆;翁小刚;王娅杰;蔡维艳;李琦;
展开▼

申请日2015-07-17
分类号
代理机构北京华科联合专利事务所(普通合伙);
代理人王为
地址 100700 北京市东城区东直门内南小街16号
入库时间 2023-12-18 11:14:22

法律信息

法律状态公告日

法律状态信息

法律状态
2015-11-04

实质审查的生效 IPC(主分类):A61K36/8968 申请日:20150717

实质审查的生效
2015-09-30

公开

公开

相似文献

专利
中文文献
外文文献

1. 生脉饮在预防、治疗雾霾促发心肌缺血性疾病中的作用 [P] . 中国专利： CN104940595A . 2015-09-30
2. 参莲提取物在预防、治疗心肌缺血性疾病及雾霾促发心肌缺血性疾病中的作用 [P] . 中国专利： CN105055513A . 2015-11-18
3. In view of their capability to antagonize the actions of neurokinins by blocking the neurokinin receptors, and in particular antagonizing the actions of substance P by blocking the NK1 receptor, the compounds according to the invention are useful as a medicine, in particular in the prophylactic and therapeutic treatment of neurokinin-mediated conditions, such as, for instance CNS disorders, in particular depression, anxiety disorders, stress-related disorders, sleep disorders, cognitive disorders, personality disorders, schizoaffective disorders, eating disorders, neurodegenerative diseases, addiction disorders, mood disorders, sexual dysfunction, pain and other CNS-related conditions; inflammation; allergic disorders; emesis; gastrointestinal disorders, in particular irritable bowel syndrome (IBS); skin disorders; vasospastic diseases; fibrosing and collagen diseases; disorders related to immune enhancement or suppression and rheumatic diseases and body weight control. [P] . EA009217B1 . 2007-12-28

机译：考虑到它们通过阻断神经激肽受体来拮抗神经激肽的作用，特别是通过阻断NK1受体来拮抗P物质的作用的能力，根据本发明的化合物可用作药物，特别是在预防和治疗中。治疗神经激肽介导的疾病，例如中枢神经系统疾病，尤其是抑郁症，焦虑症，与压力有关的疾病，睡眠障碍，认知障碍，人格障碍，精神分裂性障碍，进食障碍，神经退行性疾病，成瘾障碍，情绪疾病，性功能障碍，疼痛和其他中枢神经系统相关疾病;炎;过敏性疾病呕吐胃肠道疾病，特别是肠易激综合症（IBS）;皮肤疾病;血管痉挛性疾病;纤维化和胶原蛋白疾病;与免疫增强或抑制，风湿性疾病和体重控制有关的疾病。
4. Methods of treating or preventing and controlling a myeloproliferative disease, reducing or preventing an adverse effect associated with the administration of a second active agent in a patient suffering from a myeloproliferative disease and enhancing the therapeutic efficacy of a myeloproliferative disease treatment, composition. pharmaceutical and kit [P] . BR0316082A . 2005-09-27

机译：在患有骨髓增生性疾病的患者中治疗或预防和控制骨髓增生性疾病，减少或预防与施用第二种活性剂相关的不良作用以及增强骨髓增生性疾病治疗组合物的治疗功效的方法。药品和试剂盒
5. the pharmaceutical method and composition for the prevention or treatment of a disease or an autoimmune or infectious condition, pharmaceutical method and composition for the prevention or treatment of a disease or a condition of blood, pharmaceutical method and composition to modulate the formation of blood cells, Pharmaceutical method and composition to intensify peripheral mobilisation of stem cell, method and pharmaceutical composition for the prevention or treatment of a disease or metabolic condition,Pharmaceutical method and composition for the prevention or treatment of conditions associated with myeloablive chemotherapy doses supported by autologous bone marrow transplantation or peripheral blood stem cells (asct) or allogeneic bone marrow transplantation (bmt),Pharmaceutical method and composition to increase the effect of a stimulating factor in blood cells, method and pharmaceutical composition to intensify the colonization of donor blood stem cells in a myeloablated recept [P] . BRPI0507822A . 2007-07-10

机译：用于预防或治疗疾病或自身免疫或感染性疾病的药物方法和组合物，用于预防或治疗疾病或血液疾病的药物方法和组合物，调节血细胞形成的药物方法和组合物，增强干细胞外周动员的药物方法和组合物，用于预防或治疗疾病或代谢病的方法和药物组合物，用于预防或治疗与自体骨髓移植支持的骨髓活性化疗剂量有关的病症的药物方法和组合物或外周血干细胞（asct）或同种异体骨髓移植（bmt），增加刺激因子在血细胞中的作用的药物方法和组合物，增强骨髓脱钙受体中供体血干细胞定植的方法和药物组合物